About the Company
We do not have any company description for Certara, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Certara, Inc.
Certara, Inc.'s (NASDAQ:CERT) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Certara's (NASDAQ:CERT) stock is up by a considerable 14% over the past week. However, we decided to pay attention ...
Certara, Inc. to Present at 43rd Annual J.P. Morgan Healthcare ...
Certara, Inc. to Present at 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025 January 02, 2025 — 04:22 pm EST Written by None for Quiver Quantitative -> ...
Certara, Inc. (CERT): A Bull Case Theory
We came across a bullish thesis on Certara, Inc. on Stock Picker’s Journey’s Substack by Gregg Jahnke. In this article, we will summarize the bulls’ thesis on CERT. Certara, Inc.’s share was trading ...
Certara, Inc. (CERT) Q2 Earnings Miss Estimates
Certara, Inc. (CERT) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.1 per share. This compares to earnings of $0.07 per share a year ago. These figures ...
Certara, Inc. to Release Second Quarter 2025 Financial Results on ...
Certara, Inc. announced it will release its second-quarter financial results for 2025 on August 6th, following market closure, with a conference call hosted by management at 5:00 PM ET to discuss ...
Circling Back On Certara (NASDAQ:CERT) | Seeking Alpha
Certara, Inc., a biosimulation software provider, has seen strong sales growth in the software division but lagging service growth. Click here for my update on CERT stock.
Certara, Inc. (CERT) Q3 2024 Earnings Conference Call Transcript
Certara, Inc. (NASDAQ:CERT) Q3 2024 Earnings Conference Call November 6, 2024 5:00 PM ETCompany ParticipantsDavid Deuchler - IR, Gilmartin Group LLCWilliam ...
What Makes Certara (CERT) an Attractive Bet? - Insider Monkey
“Initiated: Certara, Inc. (NASDAQ:CERT) – CERT is the global leader in biosimulation technology, providing software and science- based services to big pharma, biotechs, and regulatory bodies.
Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling
Certara, Inc., a global leader in biosimulation, today announced that the European Medicines Agency (EMA) has formally qualified the Simcyp® Simulator for use in regulatory submissions across the EU.
Certara, Inc. (CERT): Among the Health Information Services Stocks ...
Certara, Inc. (NASDAQ:CERT) is a technology-enabled services and software products provider for market access, biosimulation in drug discovery, regulatory submissions, and preclinical and clinical ...
Certara, Inc. (NASDAQ:CERT) Given Average Rating of “Moderate Buy ...
Vanguard Group Inc. lifted its holdings in Certara by 0.3% during the 4th quarter. Vanguard Group Inc. now owns 12,437,089 shares of the company’s stock worth $132,455,000 after buying an ...
Similar Companies
Loading the latest forecasts...